Skip to content
Sankore
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (ARETTA) · Sankore